August is Hair Loss Awareness Month — a good moment to look past the marketing and at what is actually happening inside a hair follicle, and where the science is heading.
One term you will increasingly see is secretome. It is often loosely called "stem cell hair treatment," which is misleading. Understanding the difference matters, both scientifically and legally.
Secretome Is Not a Stem Cell Treatment
A secretome is the collection of molecules that stem cells secrete — growth factors, cytokines, extracellular vesicles (including exosomes), and signalling microRNA. The cells themselves are removed during processing.
So a secretome preparation contains the messages, not the messengers. That distinction is the whole point: the interest is in cell-to-cell signalling, not in implanting living cells. In Canada, therapies involving living cells sit under a separate and much stricter regulatory pathway, and are not something a clinic can simply offer.
Why Signalling Matters in Hair Biology
Hair grows in cycles — anagen (growth), catagen (transition), telogen (rest), exogen (shedding). Hair thinning is usually not a follicle that has died, but one that has shortened its growth phase and miniaturized over successive cycles.
At the base of the follicle sits the dermal papilla, a small cluster of cells that acts as the follicle's control centre. It responds to signalling molecules. This is why researchers are interested in secretome preparations: they are studying whether concentrated signalling factors can influence the local environment around dormant or miniaturizing follicles.
The honest summary: this is a plausible and actively researched mechanism, not a settled one.
Who Tends to Ask About This
We see interest from patients across several situations:
- Hereditary thinning (androgenetic) in both men and women, often noticed first at the part line or temples
- Postpartum shedding — usually self-resolving, but distressing
- Perimenopause and menopause, when hormonal shifts change the growth phase
- Rapid weight loss, including shedding associated with GLP-1 class medications
- Stress-related shedding (telogen effluvium) after illness, surgery, or a major life event
- Aging follicles, where density gradually declines
These have very different mechanisms — which is exactly why a diagnosis matters more than a product.
Diagnosis First, Always
Before discussing any regenerative option at Richmond Anti-Aging Clinic, Dr. Charles Jiang (CPSBC, Medical Director) assesses:
- Pattern and history — where, how fast, and since when
- Scalp health — inflammation, seborrheic dermatitis, and scarring change the plan entirely
- Blood work when indicated — thyroid function, ferritin/iron studies, hormonal markers
- Whether the shedding is temporary or progressive — this single distinction changes everything
Some hair loss needs a dermatology referral. Some resolves on its own. Some is best served by established options. A responsible plan starts by ruling things out.
How It Compares to Other Regenerative Options
| What it is | Source | |
|---|---|---|
| PRP | Platelet-rich plasma concentrated from your own blood | Autologous (your own) |
| Exosome therapy | Extracellular vesicles carrying signalling cargo | Plant-derived preparations at our clinic |
| Secretome | The broader mix of secreted factors, vesicles and miRNA | Laboratory-processed, cell-free |
They overlap. PRP hair restoration has the longest clinical track record of the three. Exosome hair therapy is newer. Secretome preparations are newer still. More recent does not automatically mean better — it usually means less long-term data.
Setting Realistic Expectations
Any follicle-directed approach shares the same realities:
- Nothing works overnight. Hair cycles are measured in months. Meaningful assessment takes 3–6 months.
- A course, not a single visit. Follicle signalling responds to repeated stimulus.
- Maintenance is part of the plan, not a failure of it.
- Individual responses vary, and some patterns respond better than others.
- Combination approaches — addressing scalp health, nutrition, hormones and the follicle together — are usually more sensible than any single input.
If someone promises guaranteed regrowth, that is a reason for caution, not enthusiasm.
Frequently Asked Questions
Is this a stem cell treatment? No. A secretome preparation is cell-free — it contains factors that cells secrete, with the cells removed. Treatments involving living cells are regulated very differently in Canada.
Is it approved in Canada for hair loss? No. This is an emerging area of research. We discuss it as education, and any decision is made with a physician after assessment.
How long before I would know if something is working? Because hair grows in cycles, 3–6 months is the realistic window for judging any follicle-directed approach — with photography and objective comparison, not memory.
Should I treat early? Generally, earlier assessment gives more options. A miniaturized follicle still has more potential than one that has been dormant for many years — but the first step is diagnosis, not treatment.
The Practical Next Step
If you are noticing thinning, the most useful thing is not choosing a treatment — it is getting a proper assessment of why. Book a consultation with our medical team, available in English and Chinese, and we will start with the diagnosis.
Important: This article is for education only and is not medical advice. Stem-cell-derived secretome preparations for hair are an emerging area; they are not an approved treatment for hair loss in Canada, evidence is still developing, and results vary between individuals. Any treatment decision is made with a physician after an in-person assessment.
